Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT Fixed Dose Combinations in Uncomplicated Malaria in Cameroon
NCT01845701Phase 3Completed
- Sponsor
- University of Yaoundé I
- Start
- Mar 2010
- Primary completion
- Apr 2014
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of artesunate + amodiaquine, dihydroartemisinin + piperaquine in Plasmodium falciparum malaria, sponsored by University of Yaoundé I. Started Mar 2010; status: completed.
02
Drugs
artesunate + amodiaquinedihydroartemisinin + piperaquine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT01845701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01845701.